Medicine
Latanoprost 50 mcg/mL ophthalmic solution
Latanoprost 50 mcg/mL ophthalmic solution is a generic prescription medicine for ophthalmic use, made by 5 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store unopened bottle(s) under refrigeration at 2°C to 8°C (36°F to 46°F)…
Key facts
- Active ingredient (INN)
- Latanoprost
- Brand
- Sold under the generic name
- Strength
- 50 mcg/mL
- Dosage form
- Ophthalmic solution
- Route
- Ophthalmic
- Packs
- 1 bottle, 3 bottles, 2.5 mL and 3 more
- Manufacturers
- SandozA-S Medication SolutionsMylan PharmaceuticalsNuCare Pharmaceuticals,IncRising Pharma Holdings
- Origin register
- US FDA, United States
- Storage
- Store unopened bottle(s) under refrigeration at 2°C to 8°C (36°F to 46°F). During shipment to the patient, the bottle may be maintained at temperatures up to 40°C (104°F) for a period not exceeding 8 days. Once a bottle is opened for use, it may be stored at room temperature up to 25°C (77°F) for 6 weeks. Protect from light.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- S01EE01 Latanoprost
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 15 November 2010
- Identifiers
- RxCUI 314072DailyMed set ID e25b82a9-1b04-4b40-8472-be107a2a6731, 463ecfde-5acb-4983-969d-0c0021bfbf48, 8fb5edec-d94a-4aad-b42e-756267a3ae55 +2NDC 64980-516, 59762-0333, 50090-7062 +2Application ANDA202442, NDA020597, ANDA091449
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 bottle, dropper in 1 carton / 2.5 mL in 1 bottle, dropper | 59762-0333-2 | Mylan Pharmaceuticals | 15 November 2010 |
| 1 bottle, dropper in 1 carton / 2.5 mL in 1 bottle, dropper | 64980-516-25 | Rising Pharma Holdings | 1 September 2016 |
| 1 bottle in 1 carton / 2.5 mL in 1 bottle | 61314-547-01 | Sandoz | 7 January 2011 |
| 3 bottle in 1 carton / 2.5 mL in 1 bottle | 61314-547-03 | Sandoz | 7 January 2011 |
| 2.5 mL in 1 bottle | 50090-7062-0 | A-S Medication Solutions | 16 January 2024 |
| 1 bottle in 1 carton / 2.5 mL in 1 bottle | 68071-3884-2 | NuCare Pharmaceuticals | 13 August 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Latanoprost
Clinical summary
Latanoprost is a prostaglandin analog indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. It is available as eye drops and ophthalmic solution for topical use. MedsAcross supplies Latanoprost for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about LatanoprostFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Latanoprost prescribing information (Mylan Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Catiolanze: European public assessment report (EPAR) · European Medicines Agency
Need Latanoprost 50 mcg/mL ophthalmic solution for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.